Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years

1. Provencio, M.
2. Franco, F.
3. Gómez-Codina, J.
4. Quero Blanco, C.
5. Llanos, M.
6. Garcia-Arroyo, F.
7. de la Cruz, L.
8. Gumá, J.
9. Delgado, J.R.
10. Álvarez, R.
11. Chacón, J.I.
12. Royuela, A.
13. Rueda, A.